From: Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
Intermediate risk
High risk
Sensitivity
0 (0–45.9)
35 (15.4–59.2)
Specificity
94.4 (72.7–99.9)
96.7 (88.5–99.6)
PPV
0
77.8
NPV
73.9
81.7